Skip to content

Home / News

News

Stay at the forefront of drug delivery innovation in the contract development and manufacturing organization (CDMO) space. Explore our latest news and announcements, where the demands of today meet the possibilities of tomorrow.

Company announcement

Kindeva bolsters executive team with Chief Quality Officer appointment

ST.LOUIS, 22nd APRIL:  Kindeva, a global CDMO and drug delivery expert, has today announced the appointment of Melanie Cerullo as Chief Quality Officer to drive its quality, compliance and regulatory strategy. With a proven track record in safely delivering treatments to patients across the globe, Melanie’s appointment will bolster the organization to deliver strategic value […]
Read more

News filter

Meridian Medical Technologies, LLC, and the European Commission’s DG HERA sign agreement for 13 countries from the EEA to purchase Tecovirimat SIGA

ST. LOUIS, Mo. and WOODBURY, Minn.; Oct. 23, 2023 (Business Wire) – Meridian Medical Technologies, LLC (Meridian), a global health security leader in providing medical countermeasures, today announced a framework contract under the Joint Procurement Agreement (JPA) was signed between Meridian and the European Commission’s Directorates-General (DG) HERA (Health Emergency Preparedness and Response Authority). As […]

Read more

Kindeva Drug Delivery appoints Brian Schubmehl as Chief Human Resources Officer

WOODBURY, Minn. and ST. LOUIS, Mo.; Sept. 15, 2023 (Business Wire) — Kindeva Drug Delivery (Kindeva), a premier global drug delivery device contract development and manufacturing organization (CDMO), announced that Brian Schubmehl has joined the company as Chief Human Resources Officer. Schubmehl brings more than two decades of diverse and senior global leadership expertise that has […]

Read more

U.K. Government grant unlocks £33M investment with Kindeva Drug Delivery for greener inhaler future

WOODBURY, Minn. and ST. LOUIS, Mo.; Aug. 3, 2023 (Business Wire) — Kindeva Drug Delivery (Kindeva), a premier global drug delivery device contract development and manufacturing organization (CDMO), announced that the company has received a grant from the U.K. Government’s Life Sciences Innovation Manufacturing Fund (LSIMF), unlocking a £33 million investment with Kindeva toward enhancing […]

Read more

Viatris announces launch of Breyna™ (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the first FDA-approved generic version of Symbicort® for people with asthma and chronic obstructive pulmonary disease, in partnership with Kindeva

Launch demonstrates companies’ commitment to bringing complex generic medicines to the market to help increase patient access PITTSBURGH and WOODBURY, Minn., July 31, 2023 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the first generic version of AstraZeneca’s Symbicort® with an Abbreviated […]

Read more

Kindeva Drug Delivery, Chiesi Group, and H&T Presspart announce strategic partnership for Dose Counter Technology Production

Woodbury, Minn.; July 11, 2023 (Business Wire) – Kindeva Drug Delivery, a global leader in contract drug delivery development and manufacturing services and technology, and H&T Presspart (a division of the Heitkamp & Thumann Group), a market leader in respiratory drug delivery systems design, development, and manufacturing, are partnering with Chiesi Group, an international research-focused […]

Read more

Meridian Medical Technologies, a Kindeva Drug Delivery company, investing $100+ Million in Bridgeton, Missouri, expansion

St. Louis, Mo. and St. Paul, Minn.; April 11, 2023 (Business Wire) – Meridian Medical Technologies, a Kindeva Drug Delivery Company, a leading global contract development and manufacturing organization (CDMO) focused on drug-device combination products, announced today, during National Community Development Week, it will expand manufacturing capabilities in Bridgeton, Missouri — investing more than $100 […]

Read more

Kindeva Drug Delivery announces the appointment of David Stevens as Global CCO

ST. PAUL, Minn. and ST. LOUIS, Mo.; April 5, 2023 (Business Wire) – Kindeva Drug Delivery (Kindeva), a leading global contract development and manufacturing organization (CDMO) focused on drug-device combination products, announced that David Stevens has joined the organization as global chief commercial officer (CCO). Stevens will spearhead the commercial, business development, and research and […]

Read more

Nutriband with Kindeva Drug Delivery select Aversa™ Fentanyl abuse deterrent formulation for commercial scale manufacturing process development

ORLANDO, Fla., April 4, 2023 – Nutriband Inc.(“Company”) (NASDAQ:NTRB) (NASDAQ:NTRBW) with Kindeva Drug Delivery (“Kindeva”) have selected the target AVERSA™ formulation to take forward into commercial scale manufacturing process development for the Company’s patented lead product, AVERSA™ Fentanyl, an abuse-deterrent fentanyl transdermal system.  AVERSA™ Fentanyl contains Nutriband’s proprietary transdermal abuse deterrent technology which can be […]

Read more

Kindeva and Meridian combine: Create leading drug-device combination product CDMO

ST. PAUL, Minn. and ST. LOUIS, Mo.; Dec. 12, 2022 (Business Wire)— Kindeva Drug Delivery (“Kindeva”) and Meridian Medical Technologies (“Meridian”) announced today the completion of the transaction to combine the two companies. The combination has created a leading global contract development and manufacturing organization (“CDMO”) focused on drug-device combination products. The combination will operate […]

Read more

Let’s transform tomorrow together

Every patient deserves a brighter tomorrow. As your strategic partner, we are dedicated to building your lasting legacy and helping you fast-track healthier tomorrows. You dream it, we deliver it.